Online Dating Market Size Is Predicted To Reach A Valuation Of USD 16.4 Billion By 2030: Grand View Research Inc.

 

Online Dating Market Growth & Trends

The global online dating market size was estimated at USD 16.4 billion by 2030 and is expected to expand at a CAGR of 6.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. The key growth factors of the market include the growing subscribers of online dating mobile applications such as Match Group, Bumble, and others coupled with the rising number of smartphones across the globe. The total subscriber of the Match group increased to 10.4 million in 2020. The Match Group operates various online dating apps such as Tinder, Hinge, and others that contributed significantly to the market growth. However, the rising number of online frauds across the globe is further projected to hamper the market growth during the forecast period.

The online dating market experienced a significant increase in the overall revenue of online dating platforms and apps owing to the rising trend of online dating applications due to COVID-19 restrictions and lockdown. Additionally, under the lockdown conditions imposed in some countries owing to the pandemic, many people prefer online dating platforms in their free time. For instance, one of the leading online dating service provider Bumble Inc accounted a significant increase in paying users to 2.5 million in 2020 as compared to 2.0 million paying users in 2019.

The count of singles across the globe has been increasing lately. These individuals have a defined set of characteristics that they are looking for, their other individual and online dating enable them to find people with such characteristics. Due to this, the adoption of online dating is increasing among these individuals and thus contributing to market expansion. Furthermore, various features are being added to online dating along with the integration of new technology which helps the service provider to enhance the user experience and meet customer expectations thus further driving the market growth.

The application segment of the platform is forecast to register the highest growth rate of 7.1% over the forecast period. The growth of the market is attributed to the advancements in smartphone-based online dating app security features. This has resulted in the widespread usage of smartphone-based online dating apps such as Tinder, Bumble app, Badoo app, and others across different socio-economic classes. Furthermore, the rising penetration of smartphone users coupled with growing internet availability in emerging economies is projected to provide significant growth opportunities in the near future.

Based on revenue generation, the market is segmented into subscriptions and advertisements. Subscription is anticipated to grow at a significant CAGR during the forecast period. Based on subscription, the online dating application market is further sub-segmented into age, gender, and type. Based on gender, the online dating application market is segmented into males and females. The women segment is expected to have a higher growth rate because women now feel much safer and less hesitant to use dating platforms. The primary reason for that change is the growing number of rules and regulations around safe dating for both men and women.

Europe is estimated to hold a significant market share of more than 20% in 2021. Well-developed countries such as Germany, the U.K., and France positively contributed to the market revenue. The high market share can be credited to the strong presence of the young population and online dating platforms in the region, and the long-existing demand for online dating apps. Additionally, higher GDP, per capita income, and per capita spending on online dating platforms in European countries altogether result in a strong user base and increased adoption of online dating portals and apps across the region.

Request a free sample copy or view report summary: Online Dating Market Report

Online Dating Market Report Highlights

• North America dominated the online dating market with a revenue share of over 35% in 2021. This can be attributed to the presence of key and well-recognized players across the region.

• The application sub-segment of the platform segment is forecast to register the highest CAGR from 2022 to 2030. A significant rise in the use of smartphones and easy internet access, coupled with the significant development of online dating apps drives the application segment growth.

• By revenue generation, the subscription segment accounted for the largest revenue share of 63.1% in 2021. By subscription, the 26-34 years age group is expected to expand at the fastest CAGR during the forecast period. This is attributed to the growing young population inclined towards using dating applications and the increasing single population due to growing divorce rates in Europe and North America. According to Tinder statistics, the U.S. registered the highest number of users accounting for 7.8 million, followed by 5 million users from the U.K.

• The quarterly subscription accounted for the largest revenue share in 2021 and is anticipated to continue its dominance in upcoming years. The growth is attributed to the fact that quarterly subscriptions give the users the right time to decide whether they want to continue with premium and whether it is worth their time or money.

• The Asia Pacific is anticipated to witness the fastest growth owing rise in the number of online meetings, messaging, and marriages and increases in the number of users across the region. India and China are the dominating markets, as a growing trend of online dating coupled with changing lifestyles is driving the market growth in the region. Also, the pandemic has surged the usage of dating apps in India. Most youngsters rely on dating apps to find love and companionship by using video calls rather than meeting to get to know each other. As per industry analysis, in India, there was a 3X times increase in the user base across dating apps during Covid-19.

• Key players in the online dating market include Bumble Inc., Cupid Media Pty Ltd., Match Group, LLC (Tinder), Elite Singles, Grindr LLC, Spark Networks, Inc., eHarmony, Inc., rsvp.com.au Pty Ltd., The Meet Group, Inc, Coffee Meets Bagel, and The League App, Inc.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-online-dating-market

Online Dating Market Segmentation

Grand View Research has segmented the global online dating market based on platform, revenue generation and region:

Online Dating Platform Outlook (Revenue, USD Million; 2017 - 2030)

• Application

• Web Portals

Online Dating Revenue Generation Outlook (Revenue, USD Million; 2017 - 2030)

• Subscription

  • Age

    • 18-25 years

    • 26-34 years

    • 35-50 years

    • Above 50 years

  • Gender

    • Male

    • Female

  • Type

    • Annually

    • Quarterly

    • Monthly

• Advertisement

Online Dating Regional Outlook (Revenue, USD Million; 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

• Asia Pacific

  • China

  • India

  • Japan

• South America

  • Brazil

• Middle East & Africa

  • South Africa

List of Key Players in the Online Dating Market

• Match Group, LLC (Tinder)

• Bumble Inc.

• Grindr LLC

• eHarmony, Inc.

• Spark Networks, Inc.

• The Meet Group, Inc

• rsvp.com.au Pty Ltd.

• Coffee Meets Bagel

• Cupid Media Pty Ltd.

• Elite Singles

• The League App, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Payday Loans Market Expected to Receive Greater Traction As Manufacturers’ Contribution Swells

 

Payday Loans Market Growth & Trends

The global payday loans market size is anticipated to reach USD 6.8 billion by 2030, registering a CAGR of 3.8% during the forecast period, according to a new report by Grand View Research, Inc. Demand for payday loans is likely to grow owing to advanced technologies such as Artificial Intelligence (AI), Machine Learning (ML), and analytics being adopted by payday lenders.

COVID-19 had a negative impact on the payday loans market. According to The Washington State Department of Financial Institution’s, 2020 payday lending report, the total number of payday lending locations in Washington, U.S. reduced by 20.5% from 2019 to 2020. Moreover, the volume of payday loans also saw a reduction. People became cautious spenders owing to the economic slowdown caused by COVID-19. Moreover, some governments, such as the U.S. government, provided relief packages to help people during financially stressful condition, reducing demand for payday loans.

Many payday loan market players offer payday loans online with a simple online application process. It helps them improve the overall customer experience. Moreover, these players use advanced technologies such as AI/ML and analytics to improve the overall process. Some market players, such as the U.S.-based Speedy Cash and Title Max, have mobile applications through which their customers can manage their loans. U.S.-based Enova.com’s Colossus platform is driven by AI/ML-enabled analytics.

Request a free sample copy or view the report summary: Payday Loans Market Report

Payday Loans Market Report Highlights

• In terms of type, the storefront payday loans segment accounted for the maximum revenue share of 53.7% in 2021. This can be attributed to the presence of numerous payday lending stores. The online payday loans segment is likely to expand at the highest CAGR of 4.2% during the forecast period. This is due to the digitalization across the Banking, Financial Services, and Insurance (BFSI) sector

• Based on marital status, the single segment dominated the market with a share of 63.7% in 2021 and is also expected to expand at the highest CAGR of 4.0% during the forecast period. This can be attributed to the generally single source of income for the singles, divorced, and widowed parents which are more likely to use a payday loan as compared to married parents. The married segment accounted for a revenue share of 36.3% in 2021 and is expected to develop by a significant CAGR during the forecast period

• Based on customer age, the 31- 40 segments dominated the market with a share of 28.1% in 2021 and are expected to develop by a CAGR of 3.9% during the forecast period. This can be attributed to generally more financial responsibilities for the customers in this age group. The 21-30 segments are expected to develop the highest CAGR of 4.8% during the forecast period

• North America held the largest share of 31.0% in 2021 and is expected to retain its position throughout the forecast period. This can be attributed to the presence of numerous direct payday lenders in the region. Moreover, developed technology infrastructure is aiding the growth of the market in the region. The Asia Pacific region is anticipated to expand at the highest CAGR of more than 5.0% during the forecast period owing to the developing technology infrastructure

• In August 2021, Credit star Group’s subsidiary, Credit star Czech s.r.o, launched Monefit in the Czech Republic. Customers can finance their everyday expenses and purchases with Monefit Credit Line and Monefit Split products. Customers can pay in three installments instead of paying large amounts at once without hidden fees or any interest. This would help Credit star to increase its market share in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-payday-loans-market

Payday Loans Market Segmentation

Grand View Research has segmented the payday loans market based on type, marital status, customer age, and region:

Payday Loans Type Outlook (Revenue, USD Million, 2017 - 2030)

• Storefront Payday Loans

• Online Payday Loans

Payday Loans Marital Status Outlook (Revenue, USD Million, 2017 - 2030)

• Married

• Single

Payday Loans Customer Age Outlook (Revenue, USD Million, 2017 - 2030)

• Less than 21

• 21-30

• 31-40

• 41-50

• More than 50

Payday Loans Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Chile

  • Australia

• Middle East & Africa

  • UAE

  • Saudi Arabia

  • South Africa

List of Key Players in Payday Loans Market

• Title Max

• Cash Money

• Check City Online

• Mr. Lender

• Fast Loan UK

• Speedy Cash

• GAIN Credit

• Cash float

• Credit star Group

• Mr. Payday

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personalized Medicine Market Expected to Collect USD 922.72 Billion by the End of 2030: Grand View Research Inc.

 

Personalized Medicine Market Growth & Trends

The global personalized medicine market size is expected to reach USD 922.72 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 6.95% from 2022 to 2030 owing to the increasing incidence of diseases and the rising demand for novel therapeutic drugs. The emerging applications of personalized medicine are consistently enhanced by immense research efforts. For instance, in July 2022, researchers at the UMass Chan Medical School developed a microorganism-based personalized medicine model system to aid the understanding of variation in metabolism to gauge the connection between an individual’s genome, diet, microbiota, and associative environmental factors.

Most cancer conditions are usually caused by an underlying genetic discrepancy and can cause fatalities with progression. The cancer condition can be effectively and precisely treated by understanding specific genomic characteristics. For instance, in May 2020, Qiagen launched QIAseq pan-cancer multi-modal panel to enable robust analysis of genomic characteristics of cancer subjects to derive a broad spectrum of applications in precision medicine for the profiling of solid tumors and heme malignancies.

The market is positively driven by advancements in NGS technologies and extensive research on the human genome. There has been an increasing focus on utilizing NGS to derive personalized medicine outcomes that could potentially be used for the treatment of cancer and rare genetic disorders. For instance, Illumina declared that it will present its multiple oncology research abstracts at the European Society of Medical Oncology (ESMO) annual meeting in Paris. Their research enables personalized cancer care using comprehensive genomic profiling of biopsies to match subjects to the potential drugs and immunotherapies.

Telemedicine facilitates virtual or telephonic clinical advice to aid physical convenience. Telemedicine is increasingly trending, especially after the COVID-19 pandemic. Government and research institutes are taking substantial efforts to enhance the applications of personalized telemedicine. For instance, in August 2022, the National Cancer Institute declared a grant of USD 23 million for five years to aid the launch of Telehealth Research Centers of Excellence (TRACE) across the U.S. The program was launched with the support of the White House Cancer Moonshot to seek development and advancements in telehealth delivery for cancer care with a mission to leverage health equity.

Molecular imaging systems and medical devices are playing a primary role in emerging advancements in personalized medicine. They effectively leverage the applications of personalized medicine in the treatment of different types of cancers. For instance, in June 2022, GE Healthcare declared the release of high-end molecular imaging by using gallium-68 radioisotope for the diagnosis and monitoring of prostate cancer so as to leverage access to precision health and theranostics for personalized prostate cancer treatment at an early stage of cancer progression.

The market is in the growth phase due to emerging technological advancements along with consistent industrial efforts such as collaborations and expansions. For instance, in December 2021, Biogen Inc., and TheraPanacea declared that they have signed a collaboration that focuses on advancing digital health for personalized medicine in neuroscience.

Request a free sample copy or view report summary: Personalized Medicine Market Report

Personalized Medicine Market Report Highlights

• The overall growth of the market is attributed to the rising need for novel therapeutic drugs coupled with leveraged genetic level understanding of diseases and the rising incidence of cancers and genetic disorders across the globe

• The personalized medicine therapeutics segment is anticipated to witness high growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals. Further, the genomic medicine therapeutics segment is anticipated to grow substantially during the forecast period owing to significantly lowered costs of whole-genome sequencing

• North America dominated the market in 2021 due to the presence of key players and their intensive research for the development of novel therapies to find out curative solutions for various diseases

Access Press Release@ https://www.grandviewresearch.com/press-release/global-personalized-medicine-market

Personalized Medicine Market Segmentation

Grand View Research has segmented the global personalized medicine market on the basis of product and region:

Personalized Medicine Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Personalized Medicine Diagnostics

  • Genetic Testing

  • Direct-To-Consumer (DTC) Diagnostics

  • Esoteric Lab Services

  • Esoteric Lab Tests

• Personalized Medicine Therapeutics

  • Pharmaceutical

  • Genomic Medicine

  • Medical Devices

• Personalized Medical Care

  • Telemedicine

  • Health Information Technology

• Personalized Nutrition & Wellness

  • Retail Nutrition

  • Complementary & Alternative Medicine

Personalized Medicine Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Spain

  • Italy

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of Personalized Medicine Market

• GE Healthcare

• Illumina, Inc.

• ASURAGEN, INC.

• Abbott

• Dako A/S

• Exact Sciences Corporation

• Danaher Corporation (Cepheid, Inc.)

• Decode Genetics, Inc.

• QIAGEN

• Exagen Inc.

• Precision Biologics

• Celera Diagnostics LLC

• Biogen

• Genelex

• International Business Machines Corporation (IBM)

• Genentech, Inc.

• 23andMe, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antimicrobial Resistance Diagnostics Market Expected To Trigger A Revenue To USD 6.7 Billion By 2030: Grand View Research, Inc.

 

Antimicrobial Resistance Diagnostics Market Growth & Trends

The global antimicrobial resistance diagnostics market size is expected to reach USD 6.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increased risk of developing drug-resistant bacterial infections, especially in healthcare facilities, and increasing government & non-government bodies’ efforts to combat the threat of AMR are the major factor contributing to market growth. In addition, various strategic initiatives undertaken by leading market players to manage antimicrobial resistance are also contributing to market expansion. For instance, in March 2021, bioMerieux and GIZ collaborated to support the Nigerian center for disease control to strengthen the fight against AMR.

The rising adoption of rapid testing and PoC tests for drug-resistant bacterial infections is anticipated to augment the market over the projected period. Moreover, leading market players such as Danaher, Abbott, and others have a robust product portfolio of rapid diagnostic tests for antimicrobial-resistant infections. Furthermore, the increasing involvement of non-government bodies such as AMR Industry Alliance is assisting regulatory bodies to make strategies to boost the development of diagnostic solutions to manage antimicrobial resistance.

Increasing funding for the development of novel and automated test solutions for the diagnosis of antimicrobial-resistant infections is anticipated to boost market growth over the forecast period. For instance, in May 2022, the European Investment Bank funded more than USD 24 million to POCARED Diagnostics for the R&D of fully automated testing of microbial diseases. POCARED Diagnostics is involved in the development of novel microbiology tests that can provide results within hours.

Antimicrobial resistance is expected to rise in the coming years. Hence, demand for accurate & fast testing options is expected to increase for the effective management and progression monitoring of antimicrobial resistance. According to the CDC, the annual direct healthcare expenditure of antimicrobial resistance is around USD 20 billion in the U.S. High cost of disease management is driving the demand for rapid tests for the diagnosis of infections at an early stage.

Key market players are continuously involved in the development of novel tests to strengthen their market position. Moreover, other strategies such as acquisitions, partnerships, and collaborations are also adopted by leading players to expand their product portfolio in different parts of the globe. For instance, in August 2022, Accelerate Diagnostics and BD announced a collaboration to combat the threat of antimicrobial resistance. As per the deal, BD will provide Accelerate Diagnostics rapid diagnostic solutions for antibiotics-associated resistance to its vast customers.

Request a free sample copy or view report summary: Antimicribial Resistance Diagnostics Market Report

Antimicrobial Resistance Diagnostics Market Report Highlights

• PCR held the largest share of the technology segment in 2021 owing to the high penetration and technological advancements

• Based on pathogen segment, the Methicillin resistant staphylococcus aureus accounted for the largest share in 2021 due to the high incidence rate of MRSA infections and the surge in product launches

• In end-user, the hospital segment was the highest revenue contributor in 2021 because of higher patient admissions and high incidence of bacterial infections

• In Asia Pacific, the market is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antimicrobial-resistance-diagnostics-market

Antimicrobial Resistance Diagnostics Market Segmentation

Grand View Research has segmented the global antimicrobial resistance diagnostics market based on technology, pathogen, end user, and region:

Antimicrobial Resistance Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Microbiology Culture

• Immunoassay

• PCR

• NGS

• Mass Spectrometry

• Rapid & Point of Care

• Others

Antimicrobial Resistance Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Resistant Streptococcus Pneumoniae (DRSP)

• Drug Resistant Campylobacter (DRC)

• Clostridium Difficile (CD)

• Methicillin Resistant Staphylococcus Aureus (MRSA)

• Drug Resistant Neisseria Gonorrhoeae (DRNG)

• Drug Resistant Salmonella (DRNTS)

• Others

Antimicrobial Resistance Diagnostics End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostic Laboratories

• Pharmaceutical & Biotechnology Companies

• Others

Antimicrobial Resistance Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of Antimicrobial Resistance Diagnostics Market

• bioMerieux

• F. Hoffmann-La Roche Ltd.

• Abbott

• Hologic, Inc.

• BD

• Danaher

• Accelerate Diagnostics, Inc.

• Molsid

• Vela Diagnostics

• Visby Medical, Inc.

• OpGen

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Postpartum Products Market Analysis ,Industry Growth And Future Scope: Grand View Research Inc.

 

Postpartum Products Market Growth & Trends

The global postpartum products market size is expected to reach USD 3.90 billion by 2030, registering a CAGR of 6.5% according to a new report by Grand View Research, Inc. A rise in the pregnancy rate globally is expected to boost the demand for postpartum products. These products help to deal with the physical changes of pregnant women post-pregnancy. However, the economic crisis caused by COVID-19 in many countries across the globe has led to a considerable decline in birth rates. For instance, a survey by the National Academy of Sciences in Europe showed that 73.0% of those planning to have a child in 2020 decided to delay or abandoned their plans entirely. This is expected to impact the market growth in the long term.

The growing burden of problems during pregnancy, especially in developing countries, is likely to upsurge the adoption of postpartum products in such countries. As per the WHO, in 2017, approximately 810 women died every day from pregnancy and childbirth. In addition, the rising awareness among consumers regarding the use of safer and more effective post-partum solutions is anticipated to propel the market growth over the forecast period.

Moreover, the presence of various e-commerce sites offering postpartum products might drive the sales of the products through this sales channel over the forecast period. Motherhood Maternity, The Moms Co., Amazon, Walmart, Babylist, and Buy Buy Baby are some of the notable e-commerce sites that offer significant discounts and prompt customer service on various postpartum products owing to which people prefer to shop via the online sites.

Request a free sample copy or view the report summary: Postpartum Products Market Report

Postpartum Products Market Report Highlights

• Based on product, the breastfeeding accessories segment dominated the market with a revenue share of over 55.0% in 2020 owing to the growing awareness among new mothers regarding the benefits of postpartum products

• Based on sales channel, the hospital pharmacy (inpatient) segment dominated the market with a revenue share of over 35.0% in 2020 due to the easy availability of a wide range of postpartum products. Moreover, hospital pharmacists help consumers in seeking advice, which is an added advantage

• Asia Pacific dominated the market with a revenue share of over 40.0% in 2020. The rising awareness level, coupled with the presence of a large population in this region, is expected to boost the demand for postpartum products over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-postpartum-products-market

Postpartum Products Market Segmentation

Grand View Research has segmented the global postpartum products market based on product and sales channel:

Postpartum Products Outlook (Revenue, USD Million, 2018 - 2030)

• Breastfeeding Accessories

  • Breast Pads

  • Nipple Care Products

  • Breast Shells

  • Breastmilk Preparation & Cleaning Products

  • Breastmilk Storage & Feeding

  • Other Accessories

• Perineal Cooling Pads

• Others

Postpartum Products Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy (Inpatient)

• Retail Store

• E-commerce

• Wholesaler/Distributor

• Direct Purchase

Postpartum Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in Postpartum Products Market

• Koninklijke Philips N.V.

• Medela LLC

• Newell Brands

• Ameda

• NUBY

• Mayborn Group Limited

• Edge well Personal Care

• Handi-craft Company (Dr. Brown’s)

• Artsana S.P.A

• Medline

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sugar Substitutes Market is Estimated To Reach A Valuation of USD 10.42 Billion by 2030: Grand View Research Inc.

 

Sugar Substitutes Market Growth & Trends

The global sugar substitutes market size is expected to reach USD 10.42 billion by 2030, registering a CAGR of 5.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. Growing consumer inclination toward low-calorie foods and beverages, particularly in developing countries, are expected to propel the industry growth during the forecast period. In addition, increasing demand for immunity boosters and less-sugary products owing to the rising consumer awareness to improve their general health and well-being is expected to accelerate the industry growth. COVID-19 had forced governments to impose lockdowns, due to which more than half of people's physical activity had been reduced.

Moreover, eating has also become more common when people are binge-watching television shows at home, and in response to various types of mental stress. Individuals are increasingly concerned regarding their health as a consequence of COVID-19 casualties; this factor influenced them to seek low-calorie sugar food items. Sugar substitutes, such as tagatose, aspartame saccharine, and sorbitol are widely used in the food & beverage, healthcare, and cosmetics industries. The rising use of sugar substitutes in frozen foods, confectioneries, bakeries, and dairy is expected to benefit the industry. The increased incidences of health problems associated with sugar intake, such as diabetes and obesity, in developing markets are driving industry growth.

Furthermore, sugar substitutes are expected to benefit from fluctuating supply as well as the pricing of sugar. The market for low-calorie, plant-based, and naturally sweet ingredients has grown, with stevia and monk fruit being high-intensity plant-based sweeteners certified by FDA GRAS. Furthermore, global demand for natural and clean-label food products is increasing as consumers have become more aware of the adverse health consequences of using artificial ingredients. According to a report by the Food & Health Survey, approximately 74% of U.S. consumers avoided sugar in their diets in 2020. In addition, the number of new product innovations emphasizing plant-based products to combat rising obesity is increasing significantly.

Request a free sample copy or view the report summary: Sugar Substitutes Market Report

Sugar Substitutes Market Report Highlights

• The high-intensity sweeteners segment held the largest revenue share in 2021 as only small quantities are required to produce the equivalent sweetness as regular sugar

• The beverage application segment dominated the global industry in 2021 due to the rising demand for low-calorie sports and health drinks among consumers

• Asia Pacific is estimated to register the second-fastest growth rate during the forecast period owing to the rising number of diabetic patients in developing countries like India and China

• Europe is anticipated to witness a rapid growth rate during the forecast period owing to the presence of numerous businesses that produce sugar substitutes, including Roquette Freres, Tate & Lyle, and E. I. DuPont De Nemours, among others

• The region is also seeing a rise in the use of sugar substitutes due to the rising number of diabetic patients

• According to the World Health Organization (WHO), around 60 million people in the European Region, or 9.6% of women and 10.3% of men aged 25 years and over, have diabetes

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sugar-substitutes-market

Sugar Substitutes Market Segmentation

Grand View Research has segmented the global sugar substitutes market based on type, application, and region:

Sugar Substitute Type Outlook (Volume, Thousand Tons; Revenue, USD Million, 2017 - 2030)

• High-intensity Sweeteners

  • Natural

    • Stevia Extracts

    • Licorice Root Extracts

    • Monk Fruit Extracts

  • Artificial

    • Aspartame

    • Cyclamate

    • Saccharin

    • Sucralose

    • Others

• Low-intensity Sweeteners

  • Xylitol

  • Sorbitol

  • Maltitol

  • Mannitol

  • Trehalose

  • Isomaltulose

  • Others

• High Fructose Syrup

Sugar Substitute Application Outlook (Volume, Thousand Tons; Revenue, USD Million, 2017 - 2030)

• Food

  • Bakery

  • Confectionery

  • Dairy

  • Others

• Beverages

  • Juices

  • Functional Drinks

  • Carbonated Drinks

  • Non-Dairy

  • Milk and Dairy

  • Others

• Health & Personal Care

Sugar Substitute Regional Outlook (Volume, Thousand Tons; Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Mexico

  • RONA

• Europe

  • U.K.

  • Germany

  • France

  • Spain

  • Italy

• Asia Pacific

  • China

  • India

  • Japan

  • Indonesia

  • Australia

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • Turkey

  • South Africa

List of Key Players in Sugar Substitutes Market

• Tate & Lyle

• Cargill, Inc.

• Archer Daniels Midland Company (ADM)

• Ingredion Inc.

• Roquette Freres

• Ajinomoto Co.

• JK Sucralose Inc.

• The NutraSweet Company

• PureCircle

• E. I. DuPont De Nemours

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Glass Packaging Market is Expected to Amplify USD 37.6 Billion Value by 2030: Grand View Research Inc.

 

Pharmaceutical Glass Packaging Market Growth & Trends

The global pharmaceutical glass packaging market size is expected to surpass USD 37.6 billion by 2030, registering a CAGR of 9.2% during the forecast period, according to a new report by Grand View Research, Inc. The factors attributed to drive the market are the rapid expansion of the pharmaceutical industry, expansion in vials production during COVID-19, and growth in the commodity value of glass, augmented with recyclability. However, the increased relevance of alternate sources such as plastic is attributed to restraining the market to some extent.

The manufacturers of glass containers collaborate more closely and exchange opinions with the glass recycling supply chain, waste haulers, operators of materials recovery facilities (MRFs), glass recyclers, and consultants in order to address the opportunities and concerns with respect to the community glass recycling. For instance, in July 2022, Bormioli Pharma launched Eco Positive, a brand new range gathering all the sustainable packaging solutions manufactured by the company, including recycled glass.

Further, the pharmaceutical industry is witnessing a significant transition, and the focus on the development of pharmaceutical drugs has considerably grown during the past few years. There is rapid growth in the pharmaceutical market and research environment in emerging economies such as Brazil, China, and India, which has led to a gradual migration of economic and research activities from Europe to these fast-growing markets.

During the period 2015–2020, the markets in Brazil, China, and India grew by 11.3%, 4.8%, and 10.0% respectively as compared to average market growth of 5.0% for the top 5 European Union markets and 4.9% for the U.S. market thus, driving the market for pharmaceutical glass packaging.

However, the market for pharmaceutical glass packaging is estimated to witness a decline in the forthcoming years mainly because glass materials are expensive and are not able to provide economically viable solutions for the packaging of products for mass consumption. Plastic bottles used for pharma packaging are made of high-grade plastic which is a clear, strong, and lightweight plastic belonging to the polyester family. The adoption of plastic packaging over glass in the pharmaceutical industry is attributed to be a major restrain.

Request a free sample copy or view report summary: Pharmaceutical Glass Packaging Market Report

Pharmaceutical Glass Packaging Market Report Highlights

• In terms of revenue, the generic drug type segment is projected to ascend at a CAGR of 10.1% during the forecast period. Distrust in the quality of unbranded generic medicines by the physicians/patients, high out-of-pocket patient spending for drug purchases and insufficient government promotion of unbranded generics are likely to promote the use of branded generic drugs during the coming years

• Ampoules product segment accounted for 22.4% of revenue share in 2021. Glass ampoules have been widely used in packaging injection drugs. Ampoules are one of the most used glass-based primary packaging for injectables, and their growth is clearly being seen in the cost-sensitive markets of emerging nations

• Glass delaminating has been a growing concern and has been emphasized on by the FDA for better compatibility testing of the container & drug. The development of glass vials by pharma packaging manufacturers that reduce the chances of delaminating and breakage is estimated to result in the continuation of the trend of glass vials occupying a major market share during the coming years

• In December 2020, Bormioli Pharma S.p.A. acquired ISO Arzneiverpackungen Gmbh, a German company that specializes in the production of pharmaceutical packaging and particular tubular glass vials of Type I, II, and III designed for injectable drugs, vaccines, and chromatography markets. This acquisition has allowed the former further to broaden its range of packaging for the parenteral drugs

• Companies in the pharmaceutical glass packaging industry have been trying to improve product strength to reduce breakage during the filling of these vials. In September 2019, Corning Inc. got approval from FDA to market its Corning Valor Glass which enables superior chemical durability and improves resistance to breakage, damage, and particulate contamination

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmaceutical-glass-packaging-market

Pharmaceutical Glass Packaging Market Segmentation

Grand View Research has segmented the global pharmaceutical glass packaging market based on product, drug type, and region:

Pharmaceutical Glass Packaging Product Outlook (Volume, Million Units; Revenue, USD Million; 2017 - 2030)

• Vials

  • Small Vials

  • Large Vials

• Bottles

  • Small Bottles

  • Large Bottles

• Cartridges & Syringes

• Ampoules

Pharmaceutical Glass Packaging Drug Type Outlook (Volume, Million Units; Revenue, USD Million; 2017 - 2030)

• Generic

• Branded

• Biologic

Pharmaceutical Glass Packaging Regional Outlook (Volume, Million Units; Revenue, USD Million; 2017 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

• Central & South America

  • Brazil

• Middle East & Africa (MEA)

  • Saudi Arabia

List of Key Players of Pharmaceutical Glass Packaging Market

• Corning Incorporated

• Nipro Corporation

• SGD S.A.

• Stölzle-Oberglas GmbH

• Bormioli Pharma S.r.l

• West Pharmaceutical Services, Inc.

• Schott AG

• Gerresheimer AG

• Shandong Medicinal Glass Co., Ltd.

• Beat son Clark

• Ardagh Group S.A

• Arab Pharmaceutical Glass Co.

• Piramal Enterprises Ltd.

•  Owens-Illinois, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Smart Mirror Market Is Expected To Gain Significant Traction Over The Forecast Period: Grand View Research Inc.

 

Smart Mirror Market Growth & Trends

The global smart mirror market size is estimated to reach USD 1.01 billion in 2030 and is expected to grow at a CAGR of 8.8% from 2022 to 2030, according to a new report by Grand View Research, Inc.One of the primary reasons propelling the growth of the industry is the increase in demand for connected devices across the globe. The retail sector's growing need for smart mirrors is being driven by developments in Artificial Intelligence (AI), gesture recognition technology, Augmented Reality (AR), and connected devices. Smart mirrors also known as intelligent mirrors, mirror TVs, magic mirrors, and interactive mirrors, are gaining a competitive market share owing to their increasing adoption in commercial spaces and the hospitality industry.

Furthermore, the growing use of smart technology by individuals throughout the world is anticipated to fuel the growth of the industry. Established brands have been enhancing their product portfolios and launching innovative marketing strategies to gain traction and increase consumer engagement with the brand. For instance, in May 2021, Séura a U.S.-based designer technology company introduced high-tech illuminated mirrors for a wide range of applications including residential and hospitality use. The wall-mounted smart mirror segment held the largest revenue share in 2021. New product launches in wall-mounted installation types by manufacturers are likely to bode well with the segment growth.

Top private players including Electric Mirror, Inc., Evervue USA Inc., and MirrorMedia Ltd. primarily offer smart mirrors with the wall-mounted installation type. The wall-mounted segment is projected to register the fastest growth rate during the forecast period. The offline distribution channel segment led the industry in 2021. The broadening of offline distribution channels has led to the easy availability of smart mirrors to consumers, which is the primary driver augmenting segment growth. Electronic stores and independent retailers emerged as the key distribution channel for smart mirror brands on account of their large distribution network, goodwill, and huge customer base.

North America is likely to register the fastest CAGR during the forecast period. Increasing product launches by regional manufacturers in countries, such as the U.S. and Canada, through various e-commerce channels and company websites, are the key factors promoting the adoption of smart mirrors in the region. Furthermore, the adoption of smart homes in the U.S. reached 32% of all households in 2018, according to the 2019 data provided by the Housewares Organisation. Major players face intense competition from each other, as some of them operate at several locations and have large customer bases. The presence of many small-scale players is also leading to increased competition in the industry.

Request a free sample copy or view report summary: Smart Mirror Market Report

Smart Mirror Market Report Highlights

• The wall-mounted segment is expected to grow at the fastest CAGR from 2022 to 2030 due to the growing demand for wall-mounted smart mirrors from the residential and commercial sectors

• The commercial segment is expected to grow at the fastest CAGR from 2022 to 2030. Key companies in the industry are launching new products with innovative designs and sizes, specifically for the hospitality and commercial sectors. This drives the segment growth

• The offline distribution channel segment held the maximum revenue share in 2021. However, the online distribution channel segment is expected to register the fastest CAGR during the forecast period

• North America was the largest region in 2021 and is projected to expand further at a higher CAGR from 2022 to 2030

• This can be attributed to the rising disposable income and increasing consumers' inclination toward smart homes in the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-smart-mirror-market

Smart Mirror Market Segmentation

Grand View Research has segmented the global smart mirror market on the basis of installation type, application, distribution channel, and region:

Smart Mirror Installation Type Outlook (Revenue, USD Million, 2017 - 2030)

• Wall-mounted

• Free-Standing

Smart Mirror Application Outlook (Revenue, USD Million, 2017 - 2030)

• Residential

• Commercial

Smart Mirror Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Online

• Offline

Smart Mirror Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

• Europe

  • U.K.

  • Germany

  • France

• Asia Pacific

  • China

  • Japan

  • South Korea

  • Australia

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa

List of Key Players in Smart Mirror Market

• Electric Mirror, Inc.

• Séura

• ad notam USA LLC

• Majestic Mirror & Frame

• Avis Electronics

• Foshan Eterna Intelligent Bathroom Co., Ltd.

• MirrorMedia Ltd.

• LumiDesign

• Evervue USA Inc.

• Videotree

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Dialysis Centers Market Significant Profits Estimated to be Generated by 2030: Grand View Research Inc.

 

U.S. Dialysis Centers Market Growth & Trends

The U.S. dialysis centers market size is expected to reach USD 40.4 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.29% from 2023 to 2030. The high prevalence of End-Stage Renal Disease (ESRD) and favorable reimbursement are some of the key factors expected to boost growth. The expenditure on treatment is gradually rising due to the increasing prevalence of ESRD.

The availability of Medicare reimbursement for kidney disorder treatment is increasing the accessibility to the treatment. The Center for Medicare & Medicaid Services announced a new end-stage renal diseases treatment choice model for the maintenance & improvement in the reimbursement for chronic kidney disorder patients. The new model is encouraging the use of home-based treatment. In August 2022, the CMS expanded the eligibility for reimbursement for kidney disorder treatment. The expansion includes certain capital assets, mainly equipment used at home for treatment. This is increasing the accessibility to the services.

The patients need to travel to and fro the center for around 3 days per week, the proximity from the patient's residence is generally an important criterion for the center of choice. Hence the launch of new facilities is a key strategic initiative undertaken by major players to increase their market share. For instance, in May 2021, U.S. Renal Care, Inc. inaugurated three new facilities, one in-center facility and two focusing on home therapies. This expanded the company’s presence in the Southwest Florida region.

The COVID-19 pandemic resulted in patients facing difficulty in having an access to treatment for end-stage renal disorder, requiring multiple sessions within a month. According to the national kidney foundation, 15.8% of the patients undergoing treatment for end-stage renal disease had COVID-19 infection. The federal government & service providers promoted home treatment. In June 2021, a new campaign innovative kidney care was launched by nine leading healthcare organizations for patient options for receiving home treatment.

Request a free sample copy or view report summary: U.S. Dialysis Centers Market Report

U.S. Dialysis Centers Market Report Highlights

• Based on service, the in-center segment held the largest revenue share in 2022. This can be attributed to the need for assistance & care for the procedure, which can be facilitated better at the centers. The high preference for hemodialysis is also driving the market opportunity as it essentially requires center visits & assistance

• Based on dialysis type, hemodialysis dominated the market in 2022. This can be attributed to the preference for the segment by healthcare professionals & longer life expectancy for patients. However peritoneal dialysis is expected to have the fastest growth during the forecast period owing to the effective removal of toxic substances & high convenience of peritoneal dialysis enabling patients to independently have treatment at home

• Based on facility type, dialysis chains dominated the market in 2022. This can be attributed to the presence of such chains throughout the U.S. The availability of top-quality equipment and treatment at a lower cost compared to hospital-based facilities is driving the segment’s growth. In addition, the key players are acquiring independent facilities, resulting in most of the independent facilities being managed by chains

• Based on the region, the southeast region accounted for a significant revenue share in 2022 owing to the better accessibility to treatment and a higher elder population in the region. Florida & Georgia are among the states having the highest geriatric population in the U.S. as per the U.S. census bureau 2020 estimates

• The service providers and patients faced challenges since the onset of the COVID-19 pandemic, some of which are unique as compared to other health facilities and treatment groups. For instance, hemodialysis (HD) patients visit centers at least three times a week and during each session, the patients are exposed to all the patients concurrently receiving treatment in a particular session, and to healthcare personnel along with any additional exposure during their travel to and from the center

• Mergers & acquisitions and collaborations are being preferred by the key players, enabling them to have a competitive edge by adding value to their services. For Instance, in March 2022, Fresenius Medical Care announced a merger with InterWell Health and Cricket Health for facilitating better kidney disorder solutions

Access Press Release@ https://www.grandviewresearch.com/press-release/us-dialysis-centers-market-analysis

U.S. Dialysis Centers Market Segmentation

Grand View Research has segmented the U.S. dialysis centers market based on modality, dialysis type, facility type, and region:

U.S. Dialysis Centers Modality Outlook (Revenue, USD Billion, 2017 - 2030)

• In-center

• In-home

• SNF-based

U.S. Dialysis Centers Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Hemodialysis

• Peritoneal Dialysis

U.S. Dialysis Centers Facility Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Dialysis Chains

• Independent Facilities

• Hospital-based

U.S. Dialysis Centers Region Outlook (Revenue, USD Billion, 2017 - 2030)

• Northeast

• Southeast

• Southwest

• Midwest

• West

List of Key Players in the U.S. Dialysis Centers Market

• Fresenius Medical Care AG & Co. KGaA

• U.S. Renal Care, Inc.

• DaVita Inc.

• American Renal Associates

• Dialysis Clinic, Inc.

• Satellite Healthcare

• Northwest Kidney Centers

• Centers for Dialysis Care

• Rogosin Institute

• Dialysis Care Center

• USCF Health

• Rhode Island Hospital

• University of Iowa Hospital & Clinics

• Saint Anthony Hospital

• Rush Unit Children’s Hospital

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.